• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Enforcement Report - Week of May 29, 2024

    FDA

    Enforcement Report - Week of August 25, 2021

    FDA

    Gland Pharma`s Generic Haloperidol Decanoate Receives Tentative Approval in US

    FDA

    Zydus Healthcare`s Generic Haloperidol Decanoate Receives Approval in US

    FDA

    Cadila Healthcare gets USFDA nod for Haloperidol Decanoate injection

    ECONOMIC TIMES

    Somerset Theraps LLC’s Generic Haloperidol Decanoate Receives Approval In The US

    FDA

    Gland Pharma’s Generic Haloperidol Decanoate Receives Approval In US

    Mylan Institutional LLC, Ongoing Class II recall of Haloperidol Decanoate Injection, 50 mg/mL, For Intra Muscular Use Only, 1 mL single dose vials (NDC 67457-410-00) packaged in cartons of ten (NDC 67457-410-13), Rx only, Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103 because of Lack of Assurance of Sterility; due to leaking vials

    FDA

    Mylan Institutional LLC, Ongoing Class II recall of Haloperidol Decanoate Injection, 100 mg/mL, For Intra Muscular Use Only, 1 mL single dose vials (NDC 67457-409-00) packaged in cartons of five (NDC 67457-409-13), Rx only, Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103 because of Lack of Assurance of Sterility; due to leaking vials

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.